Circulating procoagulant MPs were isolated, quantified by prothrombinase assay and their cellular origin determined. DIC diagnosis was made according to the JAAM 2006 score. Results: Ninety-two patients were analysed and 40 had DIC during the first 24 h. Routine clotting times and factor/inhibitor activity did not allow assessing vascular cell involvement. At admission, thrombin generation and fibrinolysis were observed in both groups while impaired fibrin polymerisation was evidenced only in DIC patients. Sustained thrombin generation persisted over time in both groups at D7. While total microparticle concentrations were in the same range regardless of DIC diagnosis, specific phenotypes were already detected at admission in DIC patients. Endothelial-and leucocyte-derived MPs were higher in DIC while an increased soluble glycoprotein V/platelet ratio was delayed, underscoring the first involvement of endothelial cells and leucocytes whereas platelet activation was delayed. Endotheliumderived CD105-MPs (OR 6.55) and CD31-MPs (OR 0.49) were strongly Intensive
Abstract Purpose: Septic shockinduced disseminated intravascular coagulopathy (DIC) contributes to multiple organ failure. Mechanisms governing vascular responses to open occurrence of DIC have not yet been established. Circulating plasma microparticles (MPs), released upon cell stress, constitute a catalytic procoagulant surface and are surrogates of vascular cell activation/injury. Herein, MPs were assessed as possible markers of haemostatic and vascular dysfunction in the DIC time course. Methods: One hundred patients with septic shock from three ICUs were enrolled and their haemostatic status evaluated at admission (D1), D2, D3 and D7. Circulating procoagulant MPs were isolated, quantified by prothrombinase assay and their cellular origin determined. DIC diagnosis was made according to the JAAM 2006 score. Results: Ninety-two patients were analysed and 40 had DIC during the first 24 h. Routine clotting times and factor/inhibitor activity did not allow assessing vascular cell involvement. At admission, thrombin generation and fibrinolysis were observed in both groups while impaired fibrin polymerisation was evidenced only in DIC patients. Sustained thrombin generation persisted over time in both groups at D7. While total microparticle concentrations were in the same range regardless of DIC diagnosis, specific phenotypes were already detected at admission in DIC patients. Endothelial-and leucocyte-derived MPs were higher in DIC while an increased soluble glycoprotein V/platelet ratio was delayed, underscoring the first involvement of endothelial cells and leucocytes whereas platelet activation was delayed. Endotheliumderived CD105-MPs (OR 6.55) and CD31-MPs (OR 0.49) were strongly
Introduction
Septic shock is a life-threatening disorder with a host inflammatory response leading to multiple organ dysfunction syndrome (MODS) [1] . Coagulation activation has dual consequences with bacterial containment and thrombotic microangiopathy, eventually evolving to disseminated intravascular coagulopathy (DIC), which is frequently associated with MODS [2, 3] . Furthermore, assessment of both inflammation and haemostasis remains difficult because of major disturbances in regulatory loops [4] . According to a recent review by Gando et al. [5] , the DIC paradigm can be viewed as follows: ''the blood of patients with DIC is hypercoagulable in the circulation and difficult to clot outside the vessels''.
In clinical settings, the mechanisms governing vascular responses and the occurrence/resolution of DIC have not yet been deciphered. There are currently two coexisting DIC scoring systems, one from the International Society for Thrombosis and Haemostasis (ISTH overt 2001) [6] and the other from the Japanese Association for Acute Medicine (JAAM 2006) [7] ; both were evaluated in critically ill patients [8] [9] [10] .
The endothelium plays a central role in the pathophysiology of septic shock contributing to disseminated inflammation and coagulation [11] . Interplay among the neutrophils, endothelium, monocytes and platelets leading to endothelial injury and microvascular thrombosis is well established in the pathogenesis of both DIC and systemic inflammation and finally MODS [4] .
Microparticles (MPs) are plasma membrane submicron fragments with procoagulant properties released from stressed cells. They disseminate membrane and cytoplasmic bioactive molecules from parental to neighbouring cells [12, 13] . MP procoagulant activity is linked to phosphatidylserine (PhtdSer), an aminophospholipid contributing to additional catalytic surface for the assembly of vitamin K-dependent blood coagulation factors and to the eventual presence of tissue factor (TF). Elevated levels of MPs were first associated with thrombotic disorders and further detected as indicators of vascular stress including coagulopathy, vascular occlusion, immune evasion and infection [14, 15] . Circulating MPs have been reported during septic shock in several clinical studies [16] [17] [18] and in experimental animal models [19, 20] where MPs could behave as pathogenic markers by providing procoagulant surfaces and by acting as inflammatory vascular mediators [21] .
The present study was designed to assess phenotypic and pathophysiological implications of procoagulant PhtdSer-bearing MPs as strong biomarkers of septic shock-induced vascular dysfunction and DIC.
Patients and methods

Patients
One hundred consecutive adult patients (18-85 years old) referred for septic shock [22] and treated with norepinephrine and/or epinephrine were prospectively enrolled after admission in medical intensive care units (ICU) from three tertiary hospitals. End-stage heart (NYHA class IV), liver (Child-Pugh classification C) or evolving cancerous diseases were excluded. The Strasbourg University Hospital Ethics Committee approved this multicentre study. Informed consent was obtained from the patient or relatives at admission and confirmed by the patient. Care was provided without a specific therapeutic intervention (Table 1 and supplementary data).
Blood collection and laboratory analysis
Sampling was performed as soon as possible after patients fulfilled septic shock criteria to avoid therapeutic bias (D1) and thereafter on the following mornings (days 2, 3 and 7). Platelet poor plasma (PPP) was obtained after two centrifugations at 2,5009g for 15 min and samples were frozen at -80°C. Haemostasis was analysed on STA-R Ò Evolution (Stago) with standard commercial reagents (see supplementary data). Platelet and leucocyte counts were measured daily. Tissue-type plasminogen activator (t-PA), plasminogen activator inhibitor-1 (PAI-1), interleukin-6 (IL-6), IL-10, TNF-a, monocyte chemotactic protein-1 (MCP-1), sP-selectin and sE-selectin were quantified by ELISA-derived FlowCytomix TM beads (Bender MedSystems GmbH, Vienna, Austria). Soluble platelet glycoprotein V (sGPV) was quantified by ELISA (Stago). DIC scoring DIC scores were calculated according to the ISTH 2001 ''overt'' and JAAM 2006 [6, 7] . Early DIC was confirmed if the JAAM (based on a dynamic evaluation of platelet count and taking into account the inflammatory response in critically ill patients) score was 4 or higher during the first 24 h at admission (D1) and/or at D2.
Microparticle analysis cProcoagulant MPs were measured by prothrombinase assay and the results were expressed as nanomolar phosphatidylserine equivalents (nM eq. PhtdSer) (see supplementary data) [23] . The MP phenotype was determined using biotinylated relevant monoclonal antibodies instead of annexin-5: anti-GPIb (platelets), anti-CD11a (leucocytes), anti-CD62E (E-selectin, stimulated endothelial cells), anti-CD31 (apoptotic endothelial cells) and anti-CD105 (stimulated endothelial cells). The normal range in healthy volunteers was previously established in our laboratory [24] .
Statistical analysis
Categorical variables were described as frequency, and comparison was performed by the v 2 test or Fisher's exact test. Quantitative data were expressed as mean and standard deviation and analysed with the non-parametric KruskalWallis test. Repeated measures were analysed with ANOVA. When indicated, a linear mixed model and twoway ANOVA including post hoc analyses were performed using a t test with Bonferroni correction for multiple comparisons. Prior to performing this analysis, variables were assessed for normality and non-normally distributed variables were transformed using logarithmic, square root, inverse or exponential transformations. Multiple logistic regression models, which excluded JAAM-related parameters, were performed to explain the occurrence of DIC at D1. Table 1) . Of note, while pneumonia was less frequent (p = 0.03) during DIC, bacteraemia was significantly associated with DIC (among these, four had pneumonia, two had pyelonephritis and one had a catheter infection).
Haemostasis and septic shock
Prothrombin time was increased with subsequent low prothrombin activity occurring to a similar extent in all patients with or without DIC. Although dramatically elevated in DIC patients, D-dimer levels were increased in all patients and remained at a high range until D7. Fibrinogen, a parameter not taken into account by the JAAM 2006 score, was increased in nearly all patients and was\1 g/l in only one patient at admission. JAAM DIC scores remained \4 in almost all non-DIC patients (p = 0.61 D1-D7) and were lowered in DIC patients (p = 0.04).
Interestingly, an early rise in prothrombin F1?2 (Fig. 1a) and elevated fibrin monomers (Fig. 1b) were both observed, confirming early thrombin generation and fibrin formation, whereas decreased AT and PC revealed the consumption of natural coagulation inhibitors. In both the non-DIC and DIC groups, sustained thrombin generation and fibrinolysis persisted over time despite supportive care and restored coagulation factors and inhibitors. Nevertheless, delayed AT and PC restoration was observed in DIC patients (p \ 0.05 for time course D1-D7) (see supplementary data). Moreover, the PAI-1 plasma concentration was not significantly different in DIC and returned to baseline at D7 (p \ 0.05) with delayed improvement when DIC was present (Fig. 1c) .
Truly soluble E-selectin was elevated in both groups and at the upper range during DIC (p = 0.02), highlighting endothelial stress (Fig. 1d) . 
DIC is characterised by a specific microparticle pattern
Total MPs were in the same range in DIC and non-DIC patients but followed a different time-course pattern (Fig. 2a) . Nevertheless, compared to non-DIC patients, DIC patients exhibited a specific MP pattern. Circulating GPIb-MPs were lower in DIC (p = 0.02 vs. no DIC) (Fig. 2b) . Regardless of the DIC diagnosis, MP release was directly dependent on the platelet concentration (r 2 = 0.24, p \ 0.001), while the GPIb-MPs/platelet ratio remained stable within the normal range over time (approximately 2.5 nM/100 G).
At admission, CD11a-MP shedding, reflecting leucocyte activation, was drastically increased in the DIC group (9.2 ± 8.7 vs. 4.5 ± 2.8 nM eq. PhtdSer, p = 0.02, Fig. 2c ) while the leucocyte count was similar in both subsets. During the follow-up period, the CD11a-MPs/leucocyte count ratio remained constant in patients without DIC (0.4 nM/G) while decreasing from 1.5 nM/G to baseline values at D7 in patients with DIC (Fig. 2d) . At D7, CD11a-MP levels remained high in DIC despite normalisation of leucocyte activation with concomitant hyperleucocytosis (p \ 0.05 vs. no DIC).
Compared to non-DIC patients, CD105-MPs were dramatically increased (p \ 0.001) in DIC patients and tended to return to baseline at the end of the follow-up period (p \ 0.05) (Fig. 2e) . CD31-MPs, which are more indicative of endothelial cell apoptosis, were increased to the same extent in DIC and non-DIC patients, and remained high at D7 (Fig. 2f) . Nevertheless, one-way analysis showed that CD31-MPs were significantly lower in DIC patients at D1 (1.1 ± 1.2 vs. 1.6 ± 2.0 nM eq. PhtdSer, p \ 0.001). Interestingly, compared to untreated The time course of cell activation during septic shockinduced DIC Patients who met the DIC criteria during the first 24 h (DIC at D2) were characterised by a mixed pattern at admission. They had moderately increased D-dimers in the same range as non-DIC patients (Fig. 3a) . The platelet count was lower than that observed in non-DIC patients, but still above the cutoff value of JAAM (or ISTH) DIC scores (Fig. 3b) . Soluble GPV (sGPV), assessed as another indicator of platelet activation by thrombin, confirmed low platelet activation with a sGPV/platelet ratio in the normal range (Fig. 3c) . Nevertheless, compared to non-DIC patients, patients who met the DIC criteria at D2 presented an enhanced inflammatory burst (see supplementary data) with increased thrombin generation (prothrombin F1?2, Fig. 3d ) and endothelial cell (CD105-MPs and sEselectin) and leucocyte activation (p \ 0.05 vs. no DIC, Fig. 3e, f and see supplementary data) . At D3, these patients clearly had DIC, with increased D-dimers and a low platelet count, and platelet activation was obvious (Fig. 3a-c) . Endothelial cells and leucocytes still remained activated (Fig. 3e, f) .
Microparticles may help towards early DIC assessment
Relevant biological parameters at D1 not related to the JAAM score were challenged in a logistic regression analysis in order to explain early DIC occurrence. CD105-MPs, CD31-MPs, factor V, prothrombin F1?2 and fibrin monomers were associated with DIC (Table 2 ). In this model, PAI-1, AT, PC, sE-selectin, sP-selectin, CD11a-MPs/leucocyte ratio, IL-6, IL-10, MCP-1 and TNFa were not significantly associated with DIC.
Discussion
In septic shock, vascular injury is central and is prompted by different actors with overlapping kinetics, leading to difficulties in the deciphering of a sequential order [25] . Despite biological criteria and scores, ultimate disseminated intravascular coagulopathy is difficult to assess clinically [26, 27] . As the inflammatory cascade represents the main limitation of the ISTH overt score, the JAAM score could be more helpful in DIC detection [9, 28, 29] . Nevertheless, we found that at D1, DIC scoring had no effect on the outcome of the analysis of the variation in biomarkers, including MPs.
According to the DIC scoring criteria, we report a high incidence of ''early'' DIC diagnosed during the first 24 h and encompassing about 40 % of patients with septic shock. As previously reported, early DIC is strongly associated with septic shock severity (SAPS II) and organ failure (SOFA), but not with mortality [30] . From the present standpoint of haemostatic activation/deregulation during sepsis, one could consider a more dynamic imbalance evolving over time in patients meeting DIC criteria. Thus, the present prospective study was designed to evaluate the association between procoagulant MPs and DIC occurrence during the time course of septic shock. Our data confirm specific vascular damage whereby endothelial cell and leucocyte impairment subsequently evolves to deregulated thrombin generation and to DIC, despite therapeutic intervention. In a cell-based model of haemostasis, DIC may not only be viewed as a coagulation disorder, but also as a delayed symptom of emerging systemic vascular inflammatory disease [2, 4] .
The possibility of MP-driven coagulation is supported by the reported role of MPs in meningococcemia [31] or by the dissemination of a procoagulant signal to neutrophils and platelets [32] . Our data evidenced elevated levels of total MPs in septic patients and a concomitant rise in prothrombin F1?2, which is highly suggestive of an MP-driven activated coagulation pathway. Indeed, PhtdSer-MPs constitute an additional catalytic surface for blood coagulation that could partially compensate for the low platelet count observed during DIC. A recent report of thrombin generation triggered by platelet-MPs in an FVII-independent but FXII-dependent manner [33] raises the likelihood of a particular platelet contribution in increasing thrombin generation. Our observation of delayed platelet activation may reflect the presence of thrombin as the main agonist while GPVI activation by sub-endothelial collagen is not predominant [34] .
In view of the present data, MPs appear to behave as vascular effectors in the course of sepsis and DIC. Multivariate analysis of the MP phenotype at D1 evidenced a particular pattern that indicates an evolution to DIC whereas routine laboratory tests failed to identify patients with an ''intermediate'' platelet count range and elevated prothrombin F1?2. Furthermore, as platelet activation is not yet detectable by sGPV/platelet and sP-selectin/ platelet ratios, which remain low at D1, the MP phenotype pattern appears to be more informative with a characteristic drop in platelet-derived GPIb-MPs following a drop in platelets and a rise in leucocyte-derived CD11a-MPs and endothelial-derived CD105-MPs. Altogether, data from the present and other studies tend to draw a picture of DIC genesis during septic shock supported by endothelial injury after an inflammatory burst, with leucocyte recruitment [25] . Indeed, our data confirm that the very initial high levels of cytokines and chemokines prompt endothelial and leucocyte activation prior to septic shock-induced DIC [35] .
Our study also indicates that MPs are a valuable tool for the detection of late cell events in the time course of sepsis. We evidenced an original specific drop in CD105-MPs values, which returned to normal range at D7 in DIC patients. These MPs could prove to be a better indicator than CD31-MPs in the monitoring of endothelial damagedriven DIC over time.
According to the Bradford-Hill criteria, causation requires temporality. From the present standpoint, endothelial and leucocyte activation precedes DIC diagnosis with CD105-MPs appearing to be the best predictor [36] . Furthermore, microparticle clearance from plasma is not clearly demonstrated, although their pharmacological modulation could constitute a reasonable challenge [18, 37] , while the implication of CD105 is of interest in the context of septic shock-induced DIC. Of note, patients treated in the present study with drotrecogin alfa (activated), known to have cytoprotective effects [38] , had significantly lowered CD105-MPs at D3. Finally, we highlight that routine haemostatic assays could be combined with MPs as indicators of endothelial cell and leucocyte involvement during septic shock. Using this approach, three groups of patients as opposed to two could be identified: (1) patients with low-grade vascular injury and controlled thrombin generation (no DIC), (2) patients with inflammatory burst, endothelial cell and leucocytes activation but with still-controlled thrombin generation who meet the DIC criteria at D2 (only 10 patients in our cohort) and (3) patients with endothelial and leucocyte activation resulting in deregulated thrombin generation and high-level fibrinolysis who meet the DIC criteria. We suggest that our preliminary results of MP patterns could help clinicians to improve early DIC assessment in order to allow a better stratification of patients treated for septic shock in future clinical trials. Thus, a new cohort is warranted to establish a new combined cell-based and routine clotting time score to diagnose early vascular injury during septic shock.
